Weight-based Dosing in Hemophilia A
NCT02586012
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
30
Enrollment
OTHER
Sponsor class
Stopped
Insufficient enrollment
Conditions
Hemophilia
Interventions
DRUG:
rFVIII
Sponsor
Craig Seaman